Rocket Pharmaceuticals Inc RCKT:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:05 PM EST
21.73UNCH (UNCH)
Volume
34,264
Close
21.73quote price arrow up+0.51 (+2.40%)
Volume
510,564
52 week range
7.57 - 23.48
Loading...
  • Open21.22
  • Day High22.04
  • Day Low21.00
  • Prev Close21.22
  • 52 Week High23.48
  • 52 Week High Date12/15/22
  • 52 Week Low7.57
  • 52 Week Low Date05/12/22

Key Stats

  • Market Cap1.711B
  • Shares Out78.73M
  • 10 Day Average Volume0.70M
  • Dividend-
  • Dividend Yield-
  • Beta1.22
  • YTD % Change11.04

KEY STATS

  • Open21.22
  • Day High22.04
  • Day Low21.00
  • Prev Close21.22
  • 52 Week High23.48
  • 52 Week High Date12/15/22
  • 52 Week Low7.57
  • 52 Week Low Date05/12/22
  • Market Cap1.711B
  • Shares Out78.73M
  • 10 Day Average Volume0.70M
  • Dividend-
  • Dividend Yield-
  • Beta1.22
  • YTD % Change11.04

RATIOS/PROFITABILITY

  • EPS (TTM)-3.06
  • P/E (TTM)-7.11
  • Fwd P/E (NTM)-6.52
  • EBITDA (TTM)-191.874M
  • ROE (TTM)-46.75%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)5.71%

EVENTS

  • Earnings Date02/22/2023(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Rocket Pharmaceuticals Inc

 

Content From Our Affiliates

Profile

MORE
Rocket Pharmaceuticals, Inc. is a late-stage biotechnology company advancing an integrated and sustainable pipeline of genetic therapies for rare childhood disorders with high unmet need. The Company's clinical programs using lentiviral vector (LVV)-based gene therapy are for the treatment of Fanconi Anemia (FA), a difficult to treat genetic disease that leads to bone marrow failure and potentially cancer, Leukocyte Adhesion Deficiency-I (LAD-I), a severe paediatric genetic...
Roderick Wong M.D.
Chairman of the Board
Gaurav Shah M.D.
Chief Executive Officer, Director
Kinnari Patel Pharm.D.
President, Chief Operating Officer
John Militello CPA
Interim Principal Financial Officer, Principal Accounting Officer, Vice President - Finance, Senior Controller, Treasurer
Mayo Pujols
Executive Vice President, Chief Technology Officer
Address
350 5th Ave Ste 7530
New York, NY
10118-7501
United States

Top Peers

SYMBOLLASTCHG%CHG
ACLX
Arcellx Inc
33.41+0.57+1.74%
VRDN
Viridian Therapeutics Inc
36.52+1.12+3.16%
KROS
Keros Therapeutics Inc
58.57+0.03+0.05%
RETA
Reata Pharmaceuticals Inc
43.33+1.11+2.63%
IBRX
Immunitybio Inc
3.80+0.02+0.53%